Correlative evidence suggests the involvement of principally and commonly modulated pathways of thioredoxin, superoxide dismutase, and glutathione in breast, lung, pancreatic, prostate, and colon cancers [33]. The gene discussed is TXN; the disease is malignant colon neoplasm.